Temasek posts record $308 billion portfolio, Latest Business News - The New Paper
Business

Temasek posts record $308 billion portfolio

This article is more than 12 months old

Investment company posts record $308 billion portfolio value, but warns pace of new investments could slow

Global economic growth and booming share markets helped Temasek Holdings hit record numbers last year, but it warned that near-term risks are on the horizon.

The investment company reported yesterday its net portfolio value hit a new high of $308 billion in the 12 months to March 31 - the first time it had exceeded $300 billion and up $33 billion from a year earlier. Its one-year total shareholder return was 12.19 per cent.

The numbers, outlined in the Temasek Review for the financial year, were bolstered by strong gains among key investments including DBS Group Holdings, Ping An Insurance and Alibaba Group Holding.

But Temasek warned the pace of new investments could slow in the year ahead given global growth is expected to moderate amid a riskier environment.

"Given the market outlook, we may recalibrate and slow our investment pace over the next nine to 18 months," said Mr Alpin Mehta, its managing director of investment.

During the year, Temasek invested $29 billion and divested $16 billion. The US accounted for the largest share of new investments in the 2018 financial year, followed by China and Europe. The Americas and Europe now combine to make up almost a quarter of the portfolio, behind Singapore's 27 per cent and China's 26 per cent.

Since 2011, Temasek has been increasing its focus in the technology, life sciences, agribusinesses, non-bank financial services and consumer sectors.

Those sectors accounted for almost half or $13 billion of new investments last year. Its exposure in these industries now totals $80 billion, or 26 per cent, of the total portfolio. This is up from $9 billion, or 5 per cent, of a smaller portfolio in 2011.

Early-stage investments comprise about 3 per cent of the portfolio. Investments made included Tessa Therapeutics, a Singapore-based biotech firm.

Temasek has also identified six global trends that will influence future investments: longer lifespans; rising affluence; sustainable living; smarter systems; the sharing economy; and a more connected world.

Ms Sulian Tay, managing director, investment, said in a statement Temasek sees "the probability of increased downside risks in the near term".

But she noted its balance sheet and portfolio resilience give the flexibility to ride out short-term market volatility while delivering sustainable returns over the long run.

Heightening trade tensions between the US and China were also addressed yesterday at a briefing by Temasek's head of strategy, Mr Michael Buchanan.

"We don't expect to go into a full-blown trade war," he said but warned that if tensions remain elevated for a significant period of time, there may be an impact on corporate investment.

 

BUSINESS & FINANCE